Novel Laparoscopic Gastric Tubing with Pyloromyotomy for Treatment of Esophageal Cancer.
- Author:
Youn Keun LEE
1
;
Sook Whan SUNG
;
Jae Kil PARK
;
Cho Hyun PARK
;
Kyo Young SONG
Author Information
1. Department of Surgery, College of Medicine, The Catholic University of Korea, Seoul, Korea. skygs@catholic.ac.kr
- Publication Type:Original Article
- Keywords:
Esophageal cancer;
Minimally invasive;
Laparoscopy;
Gastric tubing;
Feasibility
- MeSH:
Adenocarcinoma;
Axis, Cervical Vertebra;
Carcinoma, Squamous Cell;
Conversion to Open Surgery;
Esophageal Neoplasms*;
Esophagectomy;
Humans;
Laparoscopy;
Lymph Node Excision;
Operative Time;
Pneumonia;
Postoperative Complications
- From:Journal of Minimally Invasive Surgery
2014;17(2):21-25
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: We report on a novel method and outcomes of laparoscopic gastric tubing with pyloromyotomy. METHODS: The abdominal procedure includes laparoscopic gastric mobilization, celiac axis lymph node dissection, formation of the gastric tube, and pyloromyotomy. Between January 2009 and April 2013, our minimally invasive esophagectomy (MIE) was performed on 54 patients with esophageal cancer. The short-term outcomes, including postoperative complications, were analyzed. RESULTS: There were no cases of conversion to open surgery. Of 54 patients, 52 patients had squamous cell carcinoma (SCC) and two had adenocarcinoma. The total operative time was 349.8+/-77.4 minutes, of which 90.6+/-27.6 minutes was required for the abdominal procedure. The mean estimated operative blood loss during the abdominal procedure was 40.0+/-355.5 ml. The postoperative complication rate was 24.1%; three patients died of pneumonia. CONCLUSION: Laparoscopic gastric tubing with pyloromyotomy is a feasible and safe treatm ent option for patients with esophageal cancer.
